反应 #69628

ord-16c12e29c27c4e31ace7baeccc73080c

反应方程式

Cl.O
hydrochloride monohydrate
Cl.O
compound IV
Cl.O
hydrochloride monohydrate
CCN(CC(=O)O)Cc1c(N)ccc(Cl)c1Cl
ethyl-N-(6-amino-2,3-dichlorobenzyl)glycine
CCN(CC(=O)O)Cc1c(N)ccc(Cl)c1Cl
compound I
CCN(CC(=O)O)Cc1c(N)ccc(Cl)c1Cl
ethyl-N-(6-amino-2,3-dichlorobenzyl)glycine
N#CBr
cyanogen bromide
O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1
anagrelide
N#CBr
cyanogen bromide
N=c1ncc2ccccc2[nH]1
compound II
N=c1ncc2ccccc2[nH]1
iminoquinazoline

溶剂

反应条件

详细条件
See reaction.notes.procedure_details.

实验过程

Commercially, as discussed in U.S. Pat. No. 5,801,245, and as shown in FIG. 1, anagrelide has been prepared as the hydrochloride monohydrate (compound IV) from the intermediate, ethyl-N-(6-amino-2,3-dichlorobenzyl)glycine (compound I) either by reaction with cyanogen bromide in hot alcoholic solution, or, preferentially, by reaction with cyanogen bromide in an aprotic solvent such as toluene to give the iminoquinazoline intermediate (compound II), which is isolated and then reacted with a base in a hot solution of alcohol to form anagrelide base (compound III).

来源

DOI: 10.6084/m9.figshare.5104873.v1专利: US08530651B2uspto-grants-2013_09